Indian Hotels gains 3% as analysts raise earnings estimates, target post Q2
Indian Hotels moved higher in a quarterly results development.
· Business Standard Mkts
Indian Hotels' Q2 consolidated profit rose 23 per cent to ₹349 crore, while its revenue saw a 21 per cent year-on-year (YoY) growth to ₹2,566 crore.
The analysis
Indian Hotels reported ₹349 crore and ₹2,566 crore, with movement of 3%, 23% and 21% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is +0.2% on the day at ₹811.65, and has returned +8.3% over three months. It is trading close to its 52-week high, so expectations were already elevated going in. The hotels & restaurants sector has moved -0.9% over the same period, so Indian Hotels is running 9.2 points ahead of its peers.
For Indian Hotels, the question is how much of this is already reflected in the price and how much re-rates the hotels & restaurants peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- In focus: Indian Hotels (INDHOTEL), in Hotels & Restaurants.
- Over three months: Indian Hotels +8.3% against Hotels & Restaurants -0.9% (9.2 points ahead).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Indian HotelsINDHOTEL · Hotels & Restaurants | ₹811.65 | +0.2% | +11.4% | +8.3% | -0.1% | 1.1× | — |
Hotels & Restaurants
1M -3.1% · 3M -0.9%
Indian Hotels
Prices as of 30 Oct 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Acutaas Chemicals among 5 stocks hitting 52-week highs; rallied up to 18% in a month
Meesho Q2 Results: Loss narrows to Rs 132 crore YoY, revenue rises 34%
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
Mid Smallcaps under pressure; Suzlon, Swiggy, STL, HFCL slip up to 10%
Why is VBL down 5% despite Q3 PAT jumps on double-digit volume growth?